Aihua Zhang
Nanxiang Hospital, Jiading District, Shanghai · Peking University Third Hospital · Department of Nephrology, Nanjing children's hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aihua Zhang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07448220 · Study on the Efficacy of Probiotics in the Treatment of Childhood Obesity and Their Effects on Gut MicrobiotaMin-Tze LIONG · active not recruiting · Overweight , Obesity · principal investigator
- Ph4NCT03123406 · Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPTKyowa Kirin China Pharmaceutical Co., Ltd. · completed · Hyperparathyroidism; Secondary, Renal · principal investigator
- Ph2NCT02540720 · The Research of Standard Diagnosis and Treatment for Severe HSP in ChildrenNanjing Children's Hospital · unknown · Henoch-Schoenlein Purpura · study chair
- Ph2NCT02532777 · The Research of Standard Diagnosis and Treatment for HSPN in ChildrenNanjing Children's Hospital · unknown · Henoch-Schoenlein Purpura Nephritis · study chair
- Ph2NCT02532790 · The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in ChildrenNanjing Children's Hospital · unknown · Henoch-Schoenlein Purpura Nephritis · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:50 UTC. The ranking covers the 200 most relevant of 295 PubMed records, and a shared surname and initials can bring in a namesake. All 295 on PubMed
- Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.N Engl J Med · 20191,331 citationsRCR 51.5
- Adverse events associated with testosterone administration.N Engl J Med · 20101,119 citationsRCR 34.6
- 966 citationsRCR 59.1
- Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.J Clin Invest · 2005770 citationsRCR 14.5
- Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication.Mol Ther · 2018563 citationsRCR 16.8
- 329 citationsRCR 13.5
- 317 citationsRCR 9.3
- 265 citationsRCR 19.2
- 256 citationsRCR 20.9
- 208 citationsRCR 29.6